Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma

• Jun S. Wei ,

  * E-mail: weij@mail.nih.gov; khanjav@mail.nih.gov (JK)

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Peter Johansson,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Li Chen,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Young K. Song,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Catherine Tolman,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Samuel Li,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Laura Hurd,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Rajesh Patidar,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Xinyu Wen,

  Affiliations Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America, Advanced Biomedical Computing Center, SAIC-Frederick, Inc., National Cancer Institute, Frederick, Frederick, Maryland, United States of America

  ⨯
• Thomas C. Badgett,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Adam T. C. Cheuk,

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Jean-Claude Marshall,

  Affiliation Women’s Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Patricia S. Steeg,

  Affiliation Women’s Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• José P. Vaqué Díez,

  Affiliation Cell Growth Regulation Section, National Institute of Dental and Craniofacial Research, Bethesda, Maryland, United States of America

  ⨯
• Yanlin Yu,

  Affiliation Cancer Modeling Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• J. Silvio Gutkind,

  Affiliation Cell Growth Regulation Section, National Institute of Dental and Craniofacial Research, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• Javed Khan

  * E-mail: weij@mail.nih.gov; khanjav@mail.nih.gov (JK)

  Affiliation Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]